Daxor Long Term Debt 2010-2011 | DXR

Daxor long term debt from 2010 to 2011. Long term debt can be defined as the sum of all long term debt fields.
Daxor Annual Long Term Debt
(Millions of US $)
2011 $
2010 $
2009 $
Daxor Quarterly Long Term Debt
(Millions of US $)
2011-12-31
2011-09-30
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31
2009-09-30
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.046B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.097B 10.34
Quest Diagnostics (DGX) United States $15.557B 16.08
DaVita (DVA) United States $11.598B 14.41
Encompass Health (EHC) United States $8.513B 21.79
Chemed (CHE) United States $8.407B 26.06
Elanco Animal Health (ELAN) United States $8.149B 21.14
Option Care Health (OPCH) United States $4.971B 18.82
RadNet (RDNT) United States $4.259B 88.69
Amedisys (AMED) United States $3.144B 22.27
LifeStance Health (LFST) United States $2.217B 0.00
Astrana Health (ASTH) United States $2.112B 28.55
Addus HomeCare (ADUS) United States $1.785B 25.54
U.S Physical Therapy (USPH) United States $1.515B 40.54
Pennant (PNTG) United States $0.681B 35.97
Aveanna Healthcare Holdings (AVAH) United States $0.521B 0.00
Atai Life Sciences (ATAI) Germany $0.273B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.027B 0.00
ATI Physical Therapy (ATIP) United States $0.022B 0.00
Psychemedics (PMD) United States $0.016B 0.00
Ontrak (OTRK) United States $0.013B 0.00
Novo Integrated Sciences (NVOS) United States $0.009B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00